Armistice Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-100,000
Closed -$8.82M 139
2021
Q1
$8.82M Buy
+100,000
New +$9.29M 0.2% 79

Other funds holding TNDM

Armistice Capital's TNDM Position: Q2 2021 in Review

Armistice Capital sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 100,000 shares — an estimated $8.82M sold.

Armistice Capital first reported a position in TNDM in Q1 2021 and held it in 1 quarter. The position peaked at $8.82M in Q1 2021. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Armistice Capital reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Armistice Capital sold 100,000 Tandem Diabetes Care shares in Q2 2021, an estimated $8.82M.
  • Armistice Capital first reported a position in Tandem Diabetes Care in Q1 2021 and held it in 1 quarter.
  • Armistice Capital's Tandem Diabetes Care position peaked at $8.82M in Q1 2021.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Armistice Capital's 13F filing for Q2 2021, filed 16 Aug 2021.